Obdobje:
Lea Knez, Janja Jazbar, Mitja KosImmunotherapy for metastatic non-small cell lung cancer: real-world data from an academic Central and Eastern European centerThe oncologist, 2025, Vol. 30, iss. 7, oyaf092, 8 str.https://academic.oup.com/oncolo/article/30/7/oyaf092/8210407
Aleksandra Klisic... [et al.]Relationship between oxidative stress and cardiovascular risk in adolescents in Montenegro International journal of molecular sciences, 2025, Vol. 26, iss. 15, [article no.] 7760, str. 1-12https://www.mdpi.com/1422-0067/26/15/7650
Lara Pavčnik ... [et al.]Use of factorial designs to reduce stability studies for parenteral drug products : determination of factor effects via accelerated stability data analysis Pharmaceutics, 2025, Vol. 17, no. 8, [article no.] 1067, 17 str.https://www.mdpi.com/1999-4923/17/8/1067#app1-pharmaceutics-17-01067
Nina Franko, Manca Vetrih and Marija Sollner DolencEvaluation of endocrine disruptome and virtualToxLab for predicting per- and polyfluoroalkyl substances binding to nuclear receptorsJournal of xenobiotics, 2025, Vol. 15, iss. 5, [article no.] 136, 21 str.https://www.mdpi.com/2039-4713/15/5/136
Panagiotis-Dimitrios Mingas ... [et al.]Development, validation and application of the dried blood spot analysis method for the determination of Ustekinumab in patients with Inflammatory bowel diseasePharmaceuticals, 2025, Vol. 18, iss. 9, article 1253, 2025, str. 1-16https://www.mdpi.com/1424-8247/18/9/1253
Anže Meden ... [et al.]Structure-activity relationship study of navarixin analogues as dual CXCR2 and CCR7 antagonists Bioorganic chemistry, 2025, Vol. 159, art. 108423, 2025, 23 str.https://www.sciencedirect.com/science/article/pii/S0045206825003037
Taja Zore ... [et al.]A cross-sectional study of laboratory parameters 5–6 months after the first COVID-19 infectionHeliyon, 2025, Vol. 11, iss. 4, [article no.] e42535, Feb. 2025, 12 str.https://www.sciencedirect.com/science/article/pii/S2405844025009156
Azra Guzonjić ... [et al.]Telomere length and oxidative stress in small cell lung cancer patients: changes through chemotherapy cycles compared to healthy controlsBiochemia medica, 2025, Vol. 35, issue 2, art. 020705, 2025, 12 str.https://biochemia-medica.com/en/journal/35/2/10.11613/BM.2025.020705
Katarina Rede ... [et al.]The advancement of in vitro lipolysis: two-step flow-through method for the evaluation of lipid-based drug delivery systemsPharmaceutics, 2025, Vol. 17, iss. 5, [article no.] 545, 21 str.https://www.mdpi.com/1999-4923/17/5/545
Lara Smrdel ... [et al.]Catalytic proteasome subunits are heterogeneously active in human platelets with β1i playing a role in signaling and granule releaseBiochimica et biophysica acta. BBA, Molecular cell research, 2025, Vol. 1872, iss. 5, [article] 119961, str. 1-4https://www.sciencedirect.com/science/article/pii/S0167488925000667